SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination

por Crespo, Javier, Díaz-González, Álvaro, Iruzubieta, Paula, Llerena, Susana, Cabezas, Joaquín
Publicado 2021

Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points

por Fondevila, Marcos F., Mercado-Gómez, Maria, Rodríguez, Amaia, Gonzalez-Rellan, Maria J., Iruzubieta, Paula, Valentí, Víctor, Escalada, Javier, Schwaninger, Markus, Prevot, Vincent, Dieguez, Carlos, Crespo, Javier, Frühbeck, Gema, Martinez-Chantar, Maria L., Nogueiras, Ruben
Publicado 2021

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

por Crespo, Javier, Lazarus, Jeffrey V., Iruzubieta, Paula, García, Federico, García-Samaniego, Javier
Publicado 2021

HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?

por Crespo, Javier, Díaz-González, Álvaro, Cabezas, Joaquín
Publicado 2021

Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.

por Sempere, Elena Diago, Matilla, Ana, Rodríguez, Carlos, Perelló, Christie, Minguez, Beatriz, Varela, Maria, Urquijo, Juan José, Ampuero, Javier, Prieto, Janire, Pérez, Laura Márquez, Crespo, Javier, Bermúdez, María, Piedra Cerezal, Ana Maria, Diago, Moises, Antoran, Belén Ruiz, Calleja Panero, José Luis
Publicado 2022

Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients

por Herrán, Aitor Odriozola, Del Barrio, María, Cuadrado, Antonio, Fortea, Jose Ignacio, Amigo, Lidia, Segundo Arribas, David San, Rodríguez-Cundin, María, Rebollo, María, Fernandez, Roberto, Castillo, Federico, Achalandabaso, María, Echeverri, Juan Andrés, Rodríguez-San Juan, Juan Carlos, López-Hoyos, Marcos, Rodríguez Duque, Juan Carlos, Tellado, Álex García, Crespo, Javier, Fabrega, Emilio
Publicado 2022